<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03976167</url>
  </required_header>
  <id_info>
    <org_study_id>IB 3150/16 PI</org_study_id>
    <nct_id>NCT03976167</nct_id>
  </id_info>
  <brief_title>Comparison of Oxygen Adminstration by Nasal Cannula and High Flow Cannula During Bronchoscopy</brief_title>
  <official_title>Oxygen Administration During Bronchoscopy in Children, High Flow and Common Nasal Cannula: a Randomized Controled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Son Espases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Son Espases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controled trial to compare oxygen desaturation during fiberoptic bronchoscopy
      using oxygen administered with nasal prongs and high flow nasal cannula. Drops in oxygen
      saturation are frequent during bronchoscopy and limit the procedure compromising patient
      security. The investigator's aim is to contribute to select better way of oxygen
      administration which could prevent desaturations during bronchoscopy in children.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2015</start_date>
  <completion_date type="Actual">February 28, 2019</completion_date>
  <primary_completion_date type="Actual">February 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen desaturation</measure>
    <time_frame>Trough study completion, an average of 2 years</time_frame>
    <description>Number of patients with Oxygen saturation under 94% during bronchoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Moderate oxygen desaturations</measure>
    <time_frame>Trough study completion, an average of 2 years</time_frame>
    <description>Number of patients with Oxygen saturation &lt; 94% and &gt; 90 %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe oxygen desaturations</measure>
    <time_frame>Trough study completion, an average of 2 years</time_frame>
    <description>Number of patients with Oxygen saturation&lt; 90%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tachypnea</measure>
    <time_frame>Trough study completion, an average of 2 years</time_frame>
    <description>Number of patients with Breath rate more than p95 fore age for more than 30 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apnea</measure>
    <time_frame>Trough study completion, an average of 2 years</time_frame>
    <description>Number of patients with Breath rate 0 for more than 20 seconds or recure intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bradycardia</measure>
    <time_frame>Trough study completion, an average of 2 years</time_frame>
    <description>Number of patients with Heart rate less than p5 forte age for more than 20 seconds</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Respiratory Disease</condition>
  <arm_group>
    <arm_group_label>Common nasal cannula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxygen administration up to 4 liters according defined protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal cannula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen administered with high flow nasal cannula according child weight and protocol designed for this study</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen administration with Common nasal cannula</intervention_name>
    <description>Oxygen administration during elective flexible bronchoscopy in children with high flow nasal cannula with inspired oxygen fraction 1.</description>
    <arm_group_label>Common nasal cannula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen administration with high flow nasal cannula, device Airvo2 Fisher and Pykel</intervention_name>
    <arm_group_label>High flow nasal cannula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective flexible bronchoscopy

        Exclusion Criteria:

          -  admitted in Neonatal intensive care

          -  previous respiratory support: oxygen any device, non invasive or invasive ventilation

          -  patient who may benefit with continuous positive pressure during procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Artur sharluyan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ib-salut</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastian Sailer, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ib-salud</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco de Borja Osona Rodriguez, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Ib-salud</affiliation>
  </overall_official>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2019</study_first_posted>
  <last_update_submitted>June 6, 2019</last_update_submitted>
  <last_update_submitted_qc>June 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Desaturations</keyword>
  <keyword>Bronchoscopy</keyword>
  <keyword>Oxygen</keyword>
  <keyword>High flow oxygen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

